以岭药业

- 002603

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
以岭药业(002603) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入252,263.271,031,831.29857,467.83679,056.16393,495.66
营业收入252,263.271,031,831.29857,467.83679,056.16393,495.66
二、营业总成本216,333.10871,919.63657,676.15490,393.41248,934.28
营业成本122,406.07440,780.91334,304.84259,836.38137,867.71
营业税金及附加4,432.2313,512.7511,021.617,869.044,611.55
销售费用56,776.37270,466.24208,997.44152,465.2973,172.87
管理费用13,815.6359,204.1843,036.0829,488.5416,748.22
财务费用843.572,636.81945.31473.3049.52
研发费用18,059.2585,318.7359,370.8840,260.8716,484.41
资产减值损失----------
公允价值变动收益1,295.303,935.384,442.562,770.011,055.75
投资收益381.462,595.04-38.96256.22-437.85
其中:对联营企业和合营企业的投资收益-0.29-1.51-1.00-0.98--
汇兑收益----------
三、营业利润39,139.43177,982.75212,871.21193,835.98145,686.68
加:营业外收入82.65843.96386.17275.88158.20
减:营业外支出2,376.5110,405.582,648.44772.71226.46
其中:非流动资产处置损失----------
四、利润总额36,845.56168,421.14210,608.93193,339.15145,618.43
减:所得税费用6,653.5933,990.8735,215.2633,034.1225,474.75
五、净利润30,191.97134,430.27175,393.67160,305.03120,143.68
归属于母公司所有者的净利润30,392.79135,237.92175,868.44160,602.10120,251.44
少数股东损益-200.82-807.66-474.77-297.07-107.76
六、每股收益
基本每股收益(元/股)0.18190.80951.05270.96130.7200
稀释每股收益(元/股)0.18190.80951.05270.96130.7200
七、其他综合收益-3.3260.4689.4099.3834.41
八、综合收益总额30,188.65134,490.73175,483.08160,404.41120,178.10
归属于母公司所有者的综合收益总额30,389.47135,298.38175,957.84160,701.48120,285.85
归属于少数股东的综合收益总额-200.82-807.66-474.77-297.07-107.76
下载全部历史数据到excel中 返回页顶